Clinical trial
Precision Medicine in Systemic Sclerosis Gastrointestinal Disease: Evaluating Imaging and Stool Biomarkers for Differentiating Disease Stages and Treatment Responses
NCT04630782 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Precision Medicine in Systemic Sclerosis Gastrointestinal Disease: Evaluating Imaging and Stool Biomarkers for Differentiating Disease Stages and Treatment Responses
- Lead sponsor
- Singapore General Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 9, 2020
- Completion date
- January 31, 2023
- Enrollment
- 70 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
scleroderma, systemic sclerosis